Arbutus Biopharma Corporation
Nasdaq ABUS · Warminster, PA
Works in GI & liver · Infectious disease
Arbutus Biopharma Corporation is a clinical trial sponsor based in Warminster, PA, listed as Nasdaq ABUS. It has 1 active clinical trial with 50 planned participants, in GI & liver and Infectious disease. Since 2021 it has completed 2 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq ABUS
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Arbutus Biopharma Corporation
Arbutus Biopharma Corporation is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 50 planned participants, in GI & liver, Infectious disease. Since 2021 it has completed 2 trials and stopped 2 early.
Arbutus Biopharma Corporation is based in Warminster, PA and is listed as Nasdaq ABUS. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Arbutus Biopharma Corporation; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-04-29.
Approve Suite is not affiliated with Arbutus Biopharma Corporation.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.